查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
氯胺酮治疗诊所市场:不同治疗，疗法，介绍原，各国，各地区- 产业分析，市场规模，市场占有率，2023-2030年预测
市场调查报告书
商品编码
1320173

氯胺酮治疗诊所市场:不同治疗，疗法，介绍原，各国，各地区- 产业分析，市场规模，市场占有率，2023-2030年预测

Ketamine Clinics Market with COVID-19 Impact Analysis, By Treatment, By Therapy, By Referral Source, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年氯胺酮治疗诊所市场规模将达到 87.045 亿美元，2023 年至 2030 年复合年增长率为 11.3%

氯胺酮治疗诊所市场 - 市场动态：

研究和临床试验以及对氯胺酮不断增长的需求推动市场成长

精神疾病的盛行率不断上升，加上传统治疗的局限性，正在推动对氯胺酮等替代疗法的需求。此外，随着早期研究显示出积极的结果，需要更多的临床试验和研究来确定氯胺酮治疗心理健康问题的长期安全性和有效性。此外，随着研究的发展，对氯胺酮作为治疗选择的看法和接受程度可能会改变。此外，随着氯胺酮疗法获得认可，一些知名诊所和精神科诊所已开始将其纳入其产品阵容。然而，氯胺酮治疗的保险范围可能会构成重大挑战，这可能会限制预测期内氯胺酮治疗诊所的市场成长。

氯胺酮治疗诊所市场 - 主要见解：

  • 由于精神健康状况的盛行率上升以及传统治疗的局限性，预计氯胺酮治疗诊所行业将以显着的速度增长
  • 根据治疗区隔，预计现场治疗将在不久的将来占最大的市场占有率
  • 根据治疗区隔，忧郁症将在 2022 年成为主要类型
  • 按地区划分，北美将成为 2022 年主要收入来源

氯胺酮治疗诊所市场 - 区隔分析：

全球氯胺酮治疗诊所市场根据治疗、转诊来源和地区进行区隔。

市场依治疗分为三类：焦虑、忧郁、创伤后压力症候群和其他。由于患有严重忧郁症的成年人数量不断增加，忧郁症类别可能会占最大的销售占有率。氯胺酮也因其治疗忧郁症的潜在用途而引起医学界的关注。此外，氯胺酮治疗诊所正在成为为患有忧郁症和其他情绪障碍的患者提供氯胺酮治疗的专业中心。

市场分为两类：线上治疗和现场治疗。在预测期内，现场治疗将占市场占有率。对于精神疾病，氯胺酮治疗接受度的提高促使了氯胺酮的扩张，进一步推动了该领域的成长。此外，咨商师、心理学家和精神科医生等心理健康专业人员也为患者提供治疗课程。

根据转诊来源，市场分为三类：初级保健医生、网路广告和心理健康专业人员。初级保健医生预计将主导市场占有率。PCP 适用于诊断和治疗多种疾病，例如焦虑症和忧郁症等精神健康障碍。此外，如果初级保健医生认为氯胺酮治疗可能有助于治疗严重或难治性忧郁症或其他心理健康问题；如果患者认为氯胺酮治疗可能有助于治疗难治性忧郁症或其他心理健康问题，则可能会被送到氯胺酮治疗诊所。心理健康问题。这些因素可能会推动该领域的成长。

氯胺酮治疗诊所市场 - 地理洞察：

从地区来看，该市场遍布北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些地区根据其开展业务的国家进一步区隔。

氯胺酮临床市场 - 竞争格局：

由于持续的鸦片类药物危机、心理健康意识的提高以及世界各地氯胺酮治疗诊所数量众多等因素，该市场正在呈现显着增长。此外，氯胺酮治疗诊所产业正专注于众多策略，例如联盟、新服务推出、併购和业务扩张，以扩大其全球市场占有率。此外，随着越来越多的提供者进入该领域，氯胺酮治疗诊所市场的竞争正在加剧。例如，2023 年 4 月，Mindbloom 宣布与 SHIFT 合作，为员工提供家庭氯胺酮治疗作为福利。此外，该合作伙伴关係还将透过 Mindbloom 为所有 SHIFT 员工提供家庭氯胺酮治疗，价格仅为正常价格的一小部分。

目录

第1章 氯胺酮治疗诊所市场概要

  • 调查范围
  • 市场估计年数

第2章 摘要整理

  • 市场明细
  • 竞争考察

第3章 氯胺酮治疗诊所主要的市场趋势

  • 氯胺酮治疗诊所推动市场要素
  • 氯胺酮治疗诊所阻碍市场要素
  • 氯胺酮治疗诊所市场机会
  • 氯胺酮治疗诊所市场未来趋势

第4章 氯胺酮治疗诊所产业调查

  • PEST分析
  • 波特的五力分析
  • 成长预测的製图
  • 法规结构的分析

第5章 氯胺酮治疗诊所市场:COVID-19影响分析

  • COVID-19前的影响分析
  • COVID-19后的影响分析

第6章 氯胺酮治疗诊所市场形势

  • 氯胺酮治疗诊所市场占有率分析，2022年
  • 各主要製造商的明细资料
    • 现有企业的分析
    • 新兴企业的分析

第7章 氯胺酮治疗诊所市场- 不同治疗

  • 概要
    • 不同治疗的市场区隔占有率分析
    • 不安
    • 忧郁症
    • PTSD
    • 其他

第8章 氯胺酮治疗诊所市场- 疗法

  • 概要
    • 疗法的市场区隔占有率分析
    • 线上疗法
    • 现场疗法

第9章 氯胺酮治疗诊所市场- 介绍原

  • 概要
    • 介绍原的市场区隔占有率分析
    • 基层护理医生
    • 线上广告
    • 心理健康专家

第10章 氯胺酮治疗诊所市场-各地区

  • 简介
  • 北美
    • 概要
    • 美国
    • 加拿大
  • 欧洲
    • 概要
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区(APAC)
    • 概要
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 其他
  • 南美
    • 概要
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概要
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第11章 主要供应商分析- 氯胺酮治疗诊所产业

  • 竞争仪表板
  • 企业简介
    • Arevipharma GmbH
    • Biotechnica Pharma Global(BPG)
    • NY Ketamine Infusions
    • Core One Labs
    • Johnson &Johnson
    • Pfizer
    • Field Trip Health and Wellness Ltd.
    • Save Minds
    • Ember
    • UQUIFA
    • Mindbloom
    • Ketamine Clinics
    • Vitalitas Denver Ketamine Clinic

第12章 分析师的全方位展望

Product Code: ANV1484

REPORT HIGHLIGHT

Ketamine clinics market size was valued at USD 8,704.5 Million in 2022, expanding at a CAGR of 11.3% from 2023 to 2030.

Ketamine clinics are defined as hospitals that engage in therapeutic purposes by administering ketamine, a dissociative anesthetic, and analgesic drug. Moreover, as a potential treatment ketamine has drawn interest for numerous mental health conditions, especially anxiety disorders, post-traumatic stress disorder (PTSD), and treatment-resistant depression. In line with this, ketamine has shown promise in offering quick relief, generally within hours, while traditional antidepressant medications may require weeks or months to show results. Furthermore, ketamine clinics traditionally provide intravenous (IV) ketamine infusions or, in other cases, other forms of ketamine administration, including oral lozenges and nasal sprays.

Ketamine Clinics Market- Market Dynamics:

Research & Clinical Trials and Increasing Demand Ketamine will boost the market growth

The increasing prevalence of mental health conditions coupled with limitations of traditional treatments, in turn; there has been a rising demand for alternative therapies such as ketamine. Moreover, with the positive outcomes in early studies, more clinical trials and investigation is required to determine the long-term safety and effectiveness of ketamine for the treatment of mental health concern. In addition, as research develops the view and acceptance of ketamine as a treatment option may shift. Furthermore, some established medical practices and mental health clinics have started including ketamine treatment as part of their product line, as ketamine therapy gains more recognition. However, insurance coverage for ketamine therapy can be a major challenge, which may restrain the ketamine clinic's market growth over the forecast period.

Ketamine Clinics Market- Key Insights:

  • As per the analysis shared by our research analyst, the ketamine clinics market is estimated to grow annually at a CAGR of around 11.3% over the forecast period (2023-2030)
  • The ketamine clinics industry is projected to grow at a significant rate due to the rising prevalence of mental health conditions and limitations of traditional treatments
  • Based on therapy segmentation, on-site therapy was predicted to show maximum market share in the near future
  • Based on treatment segmentation, depression was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Ketamine Clinics Market- Segmentation Analysis:

The global ketamine clinics market is segmented on the basis of treatment, therapy, referral source, and region.

The market is divided into three categories based on treatment: anxiety, depression, PTSD, and others. The depression segment is likely to possess the largest revenue share owing to the growing number of adults with severe major depression. Additionally, in the medical community ketamine has gained attention for its potential use in treating depression. Moreover, ketamine clinics have emerged as specialized centers that provide ketamine therapy for patients who have suffered from depression or other mood disorders.

The market is divided into two categories based on therapy: online therapy and on-site therapy. The on-site therapy segment is likely to possess the market share over the forecast period. For mental health disorders increasing acceptance of ketamine therapy is led to an expansion of ketamine, further driving the segment growth. Additionally, mental health professionals also provide therapy sessions for patients including counselors, psychologists, and psychiatrists.

The market is divided into three categories based on referral sources: primary care physicians, online advertising, and mental health professionals. The primary care physicians segment is expected to dominate the market share. PCPs are suitable to diagnose and treat numerous medical conditions, such as mental health disorders like anxiety and depression. Moreover, primary care physicians may send their patients to ketamine clinics when primary care physicians think ketamine therapy might be helpful for severe or treatment-resistant depression or other mental health concerns. Thereby such factors may propel the segment growth.

Ketamine Clinics Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Ketamine Clinics Market- Competitive Landscape:

The market is witnessing significant growth, driven by factors including the ongoing opioid crisis, rising mental health awareness, and a large number of ketamine clinics across the globe. Moreover, ketamine clinics industries are focusing on numerous strategies such as partnerships, launching new services, mergers & acquisitions, and expansions to expand their market presence worldwide. Furthermore, as more providers have entered the space the ketamine clinics market has become more competitive. For instance, in April 2023, Mindbloom announced a partnership with SHIFT to provide at-home ketamine therapy as a benefit to its employees. Additionally, through this partnership, all SHIFT employees will have access to at-home ketamine therapy for a fraction of the normal price through Mindbloom.

Recent Developments:

For instance, in January 2022, Delic Holdings Corp announced its subsidiary, Ketamine Wellness Centers (KWC), has officially expanded operations into Utah with the opening of its Salt Lake City location.

Key features of the study:

  • This proposed research study on ketamine clinics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the ketamine clinics market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for ketamine clinics market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the ketamine clinics market.
  • Impact of COVID-19 on ketamine clinics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on ketamine clinics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the ketamine clinics market, we have also included competitive landscape and key innovator analysis for the ketamine clinics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the ketamine clinics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global ketamine clinics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL KETAMINE CLINICS MARKET KEY PLAYERS

  • Arevipharma GmbH
  • Biotechnica Pharma Global (BPG)
  • NY Ketamine Infusions
  • Core One Labs
  • Johnson & Johnson
  • Pfizer
  • Field Trip Health and Wellness Ltd.
  • Save Minds
  • Ember
  • UQUIFA
  • Mindbloom
  • Ketamine Clinics
  • Vitalitas Denver Ketamine Clinic

GLOBAL KETAMINE CLINICS MARKET, BY TREATMENT

  • Anxiety
  • Depression
  • PTSD
  • Others

GLOBAL KETAMINE CLINICS MARKET, BY THERAPY

  • Online Therapy
  • On-Site Therapy

GLOBAL KETAMINE CLINICS MARKET, BY REFERRAL SOURCE

  • Primary Care Physicians
  • Online Advertising
  • Mental Health Professionals

GLOBAL KETAMINE CLINICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ketamine Clinics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ketamine Clinics Market Snippet by Treatment
    • 2.1.2. Ketamine Clinics Market Snippet by Therapy
    • 2.1.3. Ketamine Clinics Market Snippet by Referral Source
    • 2.1.4. Ketamine Clinics Market Snippet by Country
    • 2.1.5. Ketamine Clinics Market Snippet by Region
  • 2.2. Competitive Insights

3. Ketamine Clinics Key Market Trends

  • 3.1. Ketamine Clinics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ketamine Clinics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ketamine Clinics Market Opportunities
  • 3.4. Ketamine Clinics Market Future Trends

4. Ketamine Clinics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ketamine Clinics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ketamine Clinics Market Landscape

  • 6.1. Ketamine Clinics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ketamine Clinics Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
    • 7.1.2. Anxiety
    • 7.1.3. Depression
    • 7.1.4. PTSD
    • 7.1.5. Others

8. Ketamine Clinics Market - By Therapy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy, 2022&2030 (%)
    • 8.1.2. Online Therapy
    • 8.1.3. On-Site Therapy

9. Ketamine Clinics Market - By Referral Source

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Referral Source, 2022&2030 (%)
    • 9.1.2. Primary Care Physicians
    • 9.1.3. Online Advertising
    • 9.1.4. Mental Health Professionals

10. Ketamine Clinics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Ketamine Clinics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Ketamine Clinics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Ketamine Clinics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Ketamine Clinics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Ketamine Clinics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Ketamine Clinics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Arevipharma GmbH
    • 11.2.2. Biotechnica Pharma Global (BPG)
    • 11.2.3. NY Ketamine Infusions
    • 11.2.4. Core One Labs
    • 11.2.5. Johnson & Johnson
    • 11.2.6. Pfizer
    • 11.2.7. Field Trip Health and Wellness Ltd.
    • 11.2.8. Save Minds
    • 11.2.9. Ember
    • 11.2.10. UQUIFA
    • 11.2.11. Mindbloom
    • 11.2.12. Ketamine Clinics
    • 11.2.13. Vitalitas Denver Ketamine Clinic

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Ketamine Clinics Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Ketamine Clinics Market, by Treatment2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Ketamine Clinics Market, by Therapy2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Referral Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Referral Source
  • TABLE Global Ketamine Clinics Market, by Referral Source 2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Ketamine Clinics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE EuropeKetamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)

List of Figures

  • FIGURE Ketamine Clinics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment segment market share analysis, 2022&2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy segment market share analysis, 2022&2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Referral Source segment market share analysis, 2022&2030
  • FIGURE Referral Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Ketamine Clinics Market share and leading players, 2022
  • FIGURE Europe Ketamine Clinics Market share and leading players, 2022
  • FIGURE Asia Pacific Ketamine Clinics Market share and leading players, 2022
  • FIGURE Latin America Ketamine Clinics Market share and leading players, 2022
  • FIGURE Middle East and Africa Ketamine Clinics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Germany Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Ketamine Clinics Market share analysis by country, 2022
  • FIGURE India Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Brazil Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)